New Medicare Rules Could Create "Major Burdens and Delays"

A new Medicare pilot rolling out in January will require prior authorization for 17 procedures for roughly 6.4 million traditional Medicare beneficiaries across New Jersey, Ohio, Oklahoma, Texas, Arizona and Washington, while exempting Medicare Advantage enrollees. The policy—intended to curb wasteful care—has drawn bipartisan provider and advocacy pushback, with lawmakers and state medical association leaders warning of delayed care, increased administrative burdens and the potential for beneficiaries to forgo treatment or pay out of pocket.

Analysis

Market structure: The CMS pilot (affecting ~6.4M traditional‑Medicare beneficiaries in six states starting Jan 2026) reallocates bargaining power toward payors and utilization‑management vendors and away from fee‑for‑service providers. Winners: Medicare Advantage insurers (UNH, HUM, CVS/Aetna) and e prior‑auth/health‑IT vendors that scale electronic prior authorization; losers: hospitals and imaging centers in the six states where elective procedure volume could fall by low‑to‑mid single digits over 12–24 months. Pricing power shifts toward vertically integrated payors (Optum/UNH) that can monetize reduced utilization and care‑coordination.

Risk assessment: Tail risks include rapid political/legal reversal (Congress/state lawsuits) or provider strikes that restore volumes; alternatively, denial rates >10% could force CMS to expand appeals and raise provider reimbursement, reversing the savings. Time horizons: immediate (days) — muted equity moves; short‑term (weeks–months) — volatility around CMS pilot metrics, provider memos and 2025 Medicare Open Enrollment (Oct–Dec 2025); long‑term (1–3 years) — structural MA enrollee flow and consolidation in ePA vendors. Hidden dependencies: MA enrollment trends, denial-to-appeal ratios, and negotiated commercial pricing shifts will determine net margin impact.

Trade implications: Tactical longs — overweight UNH (Optum) and HUM (1–3% position sizes) to capture margin and enrollment tailwinds; tactical shorts — select hospital operators concentrated in affected states (HCA, Tenet) or pure‑play imaging chains for a 1–2% short. Options: buy 9–12 month UNH call spreads and 3–6 month HCA puts as asymmetric, capital‑efficient plays. Cross‑asset: shorten high‑yield hospital debt and municipal healthcare exposure; expect modest widening of hospital credit spreads if procedure volumes persistently decline.

Contrarian angles: Consensus focuses on patient harm and political backlash but underestimates provider adaptation — digitized ePA could cut administrative friction and favor large incumbents (Optum) faster than expected, compressing margins for mid‑sized independent players. Historical parallels (MA prior‑auth rollouts) show initial provider outcry followed by rapid vendor consolidation and share gains for vertically integrated insurers. Monitor denial rates >8–10% and MA net enrollment flows +50k/state as triggers that would materially re‑rate winners versus losers.

Key Decisions for Investors

• Establish a 2–3% long position in UNH (UnitedHealth, ticker UNH) staged 25% now and 75% into Oct–Dec 2025 Medicare Open Enrollment; target +12–18% over 12 months, stop‑loss at -6% from entry, thesis: Optum monetizes utilization management and MA enrollment tailwinds.
• Initiate a 1–2% short or buy 3–6 month OTM puts on HCA (HCA Healthcare) sized to risk tolerance; trim or cover if state denial rates fall below 5% for two consecutive CMS reports or HCA reports same‑store procedure growth >+3% quarter‑over‑quarter.
• Deploy 0.5–1% of portfolio to a 9–12 month UNH call spread (buy ATM, sell 10–15% OTM) and 0.5–1% to 3–6 month HCA puts (10–15% OTM) to capture asymmetric upside in insurers and downside in hospitals with limited premium outlay.
• Reduce exposure to high‑yield municipal/rated hospital debt by ~50 basis points of portfolio allocation and avoid adding rural hospital credits where >30% revenue is traditional Medicare; re‑enter when spreads widen >50bps or CMS publishes pilot denials <5% for two months.